The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted
Open accessAbstract
In pulmonary arterial hypertension (PAH), antiapoptotic, proliferative, and inflammatory diatheses converge to create an obstructive vasculopathy. A selective down-regulation of the Kv channel Kv1.5 has been described in human and animal PAH. The resultant increase in intracellular free Ca 2+ ([Ca 2+ ] i ) and K + ([K + ] i ) concentrations explains the pulmonary artery smooth muscle cell (PASMC) contraction, proliferation and resistance to apoptosis. The recently described PASMC hyperpolarized mitochondria and increased bcl-2 levels also contribute to apoptosis resistance in PAH. The cause of the Kv1.5, mitochondrial, and inflammatory abnormalities remains unknown. We hypothesized that these abnormalities can be explained in part by an activation of NFAT (nuclear factor of activated T cells), a Ca 2+ /calcineurin-sensitive transcription factor. We studied PASMC and lungs from six patients with and four without PAH and blood from 23 PAH patients and 10 healthy volunteers. Compared with normal, PAH PASMC had decreased Kv current and Kv1.5 expression and increased [Ca 2+ ] i , [K + ] i , mitochondrial potential (ΔΨm), and bcl-2 levels. PAH but not normal PASMC and lungs showed activation of NFATc2. Inhibition of NFATc2 by VIVIT or cyclosporine restored Kv1.5 expression and current, decreased [Ca 2+ ] i , [K + ] i , bcl-2, and ΔΨm, leading to decreased proliferation and increased apoptosis in vitro. In vivo , cyclosporine decreased established rat monocrotaline-PAH. NFATc2 levels were increased in circulating leukocytes in PAH versus healthy volunteers. CD3-positive lymphocytes with activated NFATc2 were seen in the arterial wall in PAH but not normal lungs. The generalized activation of NFAT in human and experimental PAH might regulate the ionic, mitochondrial, and inflammatory remodeling and be a therapeutic target and biomarker.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
NFAT proteins: key regulators of T-cell development and function
Macian, F. (2005) · Nature Reviews Immunology · doi:10.1038/nri1632 · Cited by 1,569
Bonnet, S., Archer, S. L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.020 · Cited by 1,530
Self-citationCrabtree, G. R., & Olson, E. N. (2002) · Cell · doi:10.1016/s0092-8674(02)00699-2 · Cited by 1,323
Voelkel, N. F., Quaife, R. A., Leinwand, L. A., Barst, R. J., McGoon, M. D., Meldrum, D. R., Dupuis, J., Long, C. S., Rubin, L. J., Smart, F. W., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.632208 · Cited by 1,250
Reversal of experimental pulmonary hypertension by PDGF inhibition
Schermuly, R. T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24838 · Cited by 1,058
Mitochondrial Membrane Potential in Living Cells
Chen, L. B. (1988) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.04.110188.001103 · Cited by 1,037
Affinity-Driven Peptide Selection of an NFAT Inhibitor More Selective Than Cyclosporin A
Aramburu, J., Yaffe, M. B., López-Rodrı́guez, C., Cantley, L. C., Hogan, P. G., & Rao, A. (1999) · Science · doi:10.1126/science.285.5436.2129 · Cited by 613
Inflammation in pulmonary arterial hypertension
Dorfmüller, P., Perros, F., Balabanian, K., & Humbert, M. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00038903 · Cited by 594
Bonnet, S., Michelakis, E. D., Porter, C. J., Andrade-Navarro, M. A., Thébaud, B., Bonnet, S., Haromy, A., Harry, G., Moudgil, R., McMurtry, M. S., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.609008 · Cited by 590
Self-citationMcMurtry, M. S., Bonnet, S., Wu, X., Dyck, J. R. B., Haromy, A., Hashimoto, K., & Michelakis, E. D. (2004) · Circulation Research · doi:10.1161/01.res.0000145360.16770.9f · Cited by 453
Self-citationYu, Y., Fantozzi, I., Remillard, C. V., Landsberg, J. W., Kunichika, N., Platoshyn, O., Tigno, D. D., Thistlethwaite, P. A., Rubin, L. J., & Yuan, J. X.-J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405908101 · Cited by 430
Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux
Shimizu, S., Eguchi, Y., Kamiike, W., Funahashi, Y., Mignon, A., Lacronique, V., Matsuda, H., & Tsujimoto, Y. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1455 · Cited by 410
Michelakis, E. D., McMurtry, M. S., Wu, X.-C., Dyck, J. R. B., Moudgil, R., Hopkins, T. A., Lopaschuk, G. D., Puttagunta, L., Waite, R., & Archer, S. L. (2002) · Circulation · doi:10.1161/hc0202.101974 · Cited by 369
Self-citationMcMurtry, M. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23203 · Cited by 368
Primary Pulmonary Hypertension: A Vascular Biology and Translational Research “Work in Progress”
Archer, S., & Rich, S. (2000) · Circulation · doi:10.1161/01.cir.102.22.2781 · Cited by 354
Self-citationDiversity in Mitochondrial Function Explains Differences in Vascular Oxygen Sensing
Michelakis, E. D., Hampl, V., Nsair, A., Wu, X., Harry, G., Haromy, A., Gurtu, R., & Archer, S. L. (2002) · Circulation Research · doi:10.1161/01.res.0000024689.07590.c2 · Cited by 309
Self-citationAttenuated K+ channel gene transcription in primary pulmonary hypertension
Yuan, X.-J., Wang, J., Juhaszova, M., Gaine, S. P., & Rubin, L. J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78495-6 · Cited by 298
Toward transcriptional therapies for the failing heart: chemical screens to modulate genes
McKinsey, T. A., & Olson, E. N. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524144 · Cited by 288
Geraci, M. W., Moore, M., Gesell, T., Yeager, M. E., Alger, L., Golpon, H., Gao, B., Loyd, J. E., Tuder, R. M., & Voelkel, N. F. (2001) · Circulation Research · doi:10.1161/01.res.88.6.555 · Cited by 267
Autoimmunity and pulmonary hypertension: a perspective
Nicolls, M. R., Taraseviciene-Stewart, L., Rai, P. R., Badesch, D. B., & Voelkel, N. F. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00045705 · Cited by 261
Pozeg, Z. I., Michelakis, E. D., McMurtry, M. S., Thébaud, B., Wu, X.-C., Dyck, J. R. B., Hashimoto, K., Wang, S., Moudgil, R., Harry, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000062688.76508.b3 · Cited by 260
Self-citationActivation of K+channels: an essential pathway in programmed cell death
Remillard, C. V., & Yuan, J. X.-J. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00041.2003 · Cited by 251
Mediation of Neuronal Apoptosis by Kv2.1-Encoded Potassium Channels
Pal, S., Hartnett, K. A., Nerbonne, J. M., Levitan, E. S., & Aizenman, E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04798.2003 · Cited by 248
Primary Pulmonary Hypertension Between Inflammation and Cancer
Voelkel, N. F., Cool, C., Lee, S. D., Wright, L., Geraci, M. W., & Tuder, R. M. (1998) · Chest · doi:10.1378/chest.114.3_supplement.225s · Cited by 221
Smirnov, S. V., Robertson, T. P., Ward, J. P., & Aaronson, P. I. (1994) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1994.266.1.h365 · Cited by 218
Guignabert, C., Izikki, M., Tu, L. I., Li, Z., Zadigue, P., Barlier-Mur, A.-M., Hanoun, N., Rodman, D., Hamon, M., Adnot, S., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000222546.45372.a0 · Cited by 196
Sustained membrane depolarization and pulmonary artery smooth muscle cell proliferation
Platoshyn, O., Golovina, V. A., Bailey, C. L., Limsuwan, A., Krick, S., Juhaszova, M., Seiden, J. E., Rubin, L. J., & Yuan, J. X.-J. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.5.c1540 · Cited by 164
NFATc3 and NFATc4 Are Required for Cardiac Development and Mitochondrial Function
Bushdid, P. B., Osińska, H. E., Waclaw, R. R., Molkentin, J. D., & Yutzey, K. E. (2003) · Circulation Research · doi:10.1161/01.res.0000077045.84609.9f · Cited by 160
Biswas, G., Guha, M., & Avadhani, N. G. (2005) · Gene · doi:10.1016/j.gene.2005.03.028 · Cited by 144
Heerdt, B. G., Houston, M. A., & Augenlicht, L. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2444 · Cited by 128
Xia, Y., McMillin, J. B., Lewis, A. L., Moore, M. L. G., Zhu, W., Williams, R. S., & Kellems, R. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1855 · Cited by 122
NFATc3-Induced Reductions in Voltage-Gated K + Currents After Myocardial Infarction
Rossow, C. F., Minami, E., Chase, E. G., Murry, C. E., & Santana, L. F. (2004) · Circulation Research · doi:10.1161/01.res.0000128406.08418.34 · Cited by 102
NFAT Regulation in Smooth Muscle
Hill‐Eubanks, D. C., Gomez, M. F., Stevenson, A. S., & Nelson, M. T. (2003) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00212-8 · Cited by 89
Spatio-Temporal Diversity of Apoptosis Within the Vascular Wall in Pulmonary Arterial Hypertension
Michelakis, E. D. (2006) · Circulation Research · doi:10.1161/01.res.0000204572.65400.a5 · Cited by 69
Self-citationKawamura, T., Ono, K., Morimoto, T., Akao, M., Iwai‐Kanai, E., Wada, H., Sowa, N., Kita, T., & Hasegawa, K. (2004) · Circulation Research · doi:10.1161/01.res.0000129701.14494.52 · Cited by 47
Cited by
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R., Mathier, M. A., McGoon, M. D., Park, M. H., Rosenson, R. S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.01.004 · Cited by 2,360
Self-citationWriting Committee Members, McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R., Mathier, M. A., McGoon, M. D., Park, M. H., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192230 · Cited by 1,093
Self-citationInflammation and immunity in the pathogenesis of pulmonary arterial hypertension
Rabinovitch, M., Guignabert, C., Humbert, M., & Nicolls, M. R. (2014) · Circulation Research · doi:10.1161/circresaha.113.301141 · Cited by 1,029
Pulmonary arterial hypertension: pathogenesis and clinical management
Thenappan, T., Ormiston, M. L., Ryan, J. J., & Archer, S. L. (2018) · BMJ · doi:10.1136/bmj.j5492 · Cited by 998
Self-citationMolecular pathogenesis of pulmonary arterial hypertension
Rabinovitch, M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33452 · Cited by 880
Metadata
- Authors
- Bonnet, S., Rochefort, G., Sutendra, G., Archer, S. L., Haromy, A., Webster, L., Hashimoto, K., Bonnet, S. N., & Michelakis, E. D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-07-03
- Volume
- 104
- Issue
- 27
- Pages
- 11418-11423
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2070002665
- Cited by
- 364
- References
- 36
- FWCI
- 17.45
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.